Product

Anti-PD-1 or PD-L1 Antibody

Aliases

anti-PD-1 or PD-L1 antibody

2 clinical trials

1 indication

Indication

Head and Neck Cancer

Clinical trial

Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related Head and Neck Squamous Cell Carcinoma

Status: Recruiting, Estimated PCD: 2025-12-31

Clinical trial

Pathological Response Adapted Decision-making of Postoperative Management for HNSCC Receiving Induction Immunotherapy and Chemotherapy

Status: Recruiting, Estimated PCD: 2025-12-30